Newstral
Article
bizjournals.com on 2017-05-15 20:41
Teva launches generic diabetes drug
Related news
- Teva launches eighth generic ADHD drugbizjournals.com
- Teva launches generic high blood pressure medicinebizjournals.com
- Teva expands recall of generic cancer drugbizjournals.com
- Generic drug giants Mylan, Teva accused of blocking congressional probepost-gazette.com
- Israel's Teva buys Allergan generic drug company for $40.5Babc3340.com
- Teva buys Allergan generic drug company for $40.5BChicago Tribune
- Teva drops bid for Mylan, buys Allergan's generic drug unit for $40.5 billionbizjournals.com
- Allergan sells generic drug company to Israel's Teva for $40.5 billionLA Times
- First generic multiple sclerosis drug, made in Cambridge, launchesbizjournals.com
- GTeva boosted as FDA delays generic Copaxoneglobes.co.il
- FAllergan sells generic drugs unit to Tevaft.com
- The Ticker / Teva launches generic version of schizophrenia drug in U.S.Haaretz
- FDA approves Teva migraine drugbizjournals.com
- Teva shares down 13% following FDA approval of generic Copaxonebizjournals.com
- FGeneric competition puts pressure on revenues at drugmaker Tevaft.com
- Teva charged in generic drugs price-fixing probebizjournals.com
- Teva gets FDA approval for first generic EpiPenbizjournals.com
- MCorcept's stock tumbles after Teva submits NDA for generic Korlymmarketwatch.com